Effect of levosimendan and predictors of recovery in patients with peripartum cardiomyopathy, a randomized clinical trial

Biteker M., Duran N. E., Kaya H., Gunduz S., Tanboga H. I., Gokdeniz T., ...More

CLINICAL RESEARCH IN CARDIOLOGY, vol.100, no.7, pp.571-577, 2011 (SCI-Expanded, Scopus) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 100 Issue: 7
  • Publication Date: 2011
  • Doi Number: 10.1007/s00392-010-0279-7
  • Journal Name: CLINICAL RESEARCH IN CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.571-577
  • Istanbul University-Cerrahpasa Affiliated: No

Abstract

Levosimendan is a promising new inodilator agent but its effectiveness in peripartum cardiomyopathy (PPCM) has not been tested in a clinical trial. The authors sought to evaluate the effect of levosimendan therapy and to determine the predictors of clinical outcome in patients with PPCM.